Jason D.
About Jason D.
Jason D. serves as the VP Associate Creative Director at BGB Group, where he has worked since 2021. He has extensive experience in the creative field, specializing in clinical storylines for healthcare brands and has held various leadership roles in notable companies throughout his career.
Work at BGB Group
Jason D. serves as the VP Associate Creative Director at BGB Group, a position he has held since 2021. In this role, he specializes in crafting clinical storylines for pharmaceutical, biotech, medical device, and diagnostic brands. He has led the creative team in securing significant projects, including the Ozempic agency of record for professional. His leadership contributes to the strategic direction and creative output of the agency.
Previous Experience in Creative Direction
Before joining BGB Group, Jason D. held various positions in creative direction across multiple organizations. He worked as an Associate Creative Director at Greater Than One from 2019 to 2021 and at Purohit Navigation, Inc. from 2017 to 2018. His experience also includes roles at Klick and LBi US, where he contributed to creative projects in the healthcare sector. His background reflects a consistent focus on innovative solutions in the creative field.
Education and Expertise
Jason D. holds a Master of Fine Arts (MFA) in Creative Writing from Brooklyn College and a Bachelor of Arts (BA) in English Literature from Florida State University. He also studied American History and Religious Studies at Loyola University New Orleans. His educational background supports his expertise in crafting narratives and developing creative strategies, particularly in the pharmaceutical and biotech industries.
Mentorship and Team Development
Jason D. is passionate about mentoring and developing junior staff within the creative team at BGB Group. He focuses on fostering talent and building strategic alliances with both internal and external partners. His commitment to team development enhances the overall creative process and contributes to the agency's success in delivering innovative solutions.
Key Projects and Contributions
Throughout his career, Jason D. has played a key role in significant projects, including the 2022 launch of CM 648 indication for 1L treatment of metastatic squamous cell carcinoma. His contributions to these initiatives demonstrate his ability to lead creative efforts in high-stakes environments, particularly within the healthcare sector.